Article

Added value of serum proteins to clinical and ultrasound information in predicting the risk of malignancy in ovarian tumors

2024-03-15

Abstract excerpt

<h4>Background</h4> The ADNEX model (Assessment of Different NEoplasias in the adnexa) is the best performing model to predict the risk of malignancy (binary) and type of malignancy (multiclass) in ovarian tumors. The immune system plays a role in the onset and progression of ovarian cancer. Preliminary research has suggested that immune-related biomarkers can help in the discrimination of ovarian tumors. We aimed...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9d683093-bc17-5456-b34f-bd110e42d4a8
DOI: 10.1101/2024.03.14.24304282

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Added value of serum proteins to clinical and ultrasound information in predicting the risk of malignancy in ovarian tumorsDOI 10.1101/2024.03.14.24304282Read

WITHDRAWN: Predicting Malignancy in Solid Adnexal Masses: An Externally Validated Machine Learning Model Integrating Conventional and Contrast-Enhanced UltrasoundSemantic proximity Read

High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancerSemantic proximity Read

Comparison of performance between O-RADS, IOTA Simple Rules Risk assessment and ADNEX model in the discrimination of ovarian Brenner tumorsSemantic proximity Read

Multi-analyte approach combining cfDNA sequencing and protein testing for early ovarian cancer detectionSemantic proximity Read

Deep plasma proteomics identifies and validates an eight-protein biomarker panel that separate benign from malignant tumors in ovarian cancerSemantic proximity Read

Diagnostic value of CA125, HE4, systemic immune‑inflammatory index (SII), fibrinogen-to-albumin ratio(FAR), and prognostic nutritional index(PNI) in the Preoperative Investigation of ovarian MassesSemantic proximity Read

Development and Internal Validation of a Simplified Non-Contrast MRI Risk Model for Preoperative Differentiation of Ovarian TumorsSemantic proximity Read

A multiplex platform for the identification of ovarian cancer biomarkersSemantic proximity Read

An overview of biomarkers for the ovarian cancer diagnosis.Semantic proximity Read

Proteomic signature for detection of high-grade ovarian cancer in germline BRCA mutation carriers.Semantic proximity Read

Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategiesSemantic proximity Read

Multi-biomarker panel signature as the key to diagnosis of ovarian cancerSemantic proximity Read